Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Paramita Bangun Sarana Tbk. (PBSA)

Indofarma Tbk.Trading

Paramita Bangun Sarana Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indofarma Tbk. dan Paramita Bangun Sarana Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Paramita Bangun Sarana Tbk. diperdagangkan di Rp750 (kapitalisasi pasar 2,28 T, volume 24 jam 994 rb). Perbedaan utamanya: Paramita Bangun Sarana Tbk. jauh lebih besar — sekitar 5,8× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

	INAF	PBSA
Kapitalisasi Pasar	390,51 M	2,28 T
Volume	—	994 rb
Lot	—	9,94 rb
Perputaran	—	754,23 jt
Harga Rata-rata	—	758,78
Nilai Transaksi	—	754,23 jt
Harga Ekuilibrium Indikatif	—	750
Volume Ekuilibrium Indikatif	—	56

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INAF

Lihat detail →

PBSA

Lihat detail →

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF →